PPA
RNAM

Parametric Portfolio Associates’s Avidity Biosciences RNAM Stock Holding History

Parametric Portfolio Associates’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,142
Closed -$336K – 3753
2021
Q4 		$336K Sell
14,142
-1,222
-8% -$29.2K ﹤0.01% 3238
2021
Q3 		$378K Buy
15,364
+6,461
+73% +$140K ﹤0.01% 3210
2021
Q2 		$220K Buy
+8,903
New +$207K ﹤0.01% 3373
2020
Q4 		– Sell
-11,467
Closed -$323K – 4021
2020
Q3 		$323K Sell
11,467
-11,239
-49% -$325K ﹤0.01% 3455
2020
Q2 		$642K Buy
+22,706
New +$655K ﹤0.01% 3153

Other funds holding RNAM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Parametric Portfolio Associates's RNAM Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Avidity Biosciences (RNAM) in Q1 2022, closing a stake of 14,142 shares — an estimated $336K sold.

Parametric Portfolio Associates first reported a position in RNAM in Q2 2020 and held it in 5 quarters. The position peaked at $642K in Q2 2020. 103 funds tracked by Wall St. Rank hold RNAM as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Avidity Biosciences position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 14,142 Avidity Biosciences shares in Q1 2022, an estimated $336K.
  • Parametric Portfolio Associates first reported a position in Avidity Biosciences in Q2 2020 and held it in 5 quarters.
  • Parametric Portfolio Associates's Avidity Biosciences position peaked at $642K in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Avidity Biosciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.